News
News
Quest Diagnostics and Quest Diagnostics Foundation Launch Initiative...
Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, and the Quest Diagnostics Foundation, announced a wide-ranging initiative to address and reduce health...
News
Ehave Announces Plans to Accelerate the Monetization of...
Ehave, Inc.,, a provider of digital therapeutics delivering evidence-based therapeutic interventions to healthcare patients, announced today it is accelerating plans to monetize its Ehave Dashboard....
News
Amedisys Expands Personal Care Network with BrightStar Care
Amedisys, Inc., America’s leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its agencies...
News
Massachusetts General Hospital researchers create bioluminescent tag to...
A new bioluminescent reporter that tracks DNA double stranded break (DSB) repair in cells has been developed by researchers from Massachusetts General Hospital (MGH) and...
News
Penn Medicine health system gets $2.5M to study...
Penn Medicine’s COVID Watch team has received a $2.5 million grant from the Patient-Centered Outcomes Research Institute (PCORI) to study the program’s impact, particularly among...
News
LumiraDx gets FDA EUA status for point-of-care Covid-19...
LumiraDx has secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its point-of-care Covid-19 antigen test.
LumiraDx SARS-CoV-2 antigen test has...
News
AXIM Biotechnologies, Empowered Diagnostics collaborate on Covid-19 rapid...
AXIM Biotechnologies has entered into an exclusive limited licencing, manufacturing and distribution agreement with Empowered Diagnostics on the Covid-19 rapid neutralising antibody test.
The deal has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.